Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Open Access Journal of Gynecology Research Article 19 min read

Harnessing Antioxidants for Enhanced Pregnancy Success and Fetal Development

Obeagu EI*and Obeagu GU*
* Corresponding author
ISSN: 2474-9230  10.23880/oajg-16000282  Received: February 08, 2024  Published: February 22, 2024
 — views
 69 references
PDF
Keywords
Antioxidant Supplementation Maternal-Fetal Health Oxidative Stress Pregnancy Complications Redox Balance
Abstract

Pregnancy is a dynamic physiological state marked by increased oxidative stress, presenting challenges to maternal health and fetal development. This review explores the intricate relationship between oxidative stress and pregnancy outcomes, emphasizing the potential of antioxidants as crucial mediators in maintaining a healthy balance. The role of antioxidants in mitigating cellular damage, inflammation, and adverse pregnancy outcomes is discussed, with a focus on their impact on reproductive success and long-term fetal development. Key antioxidants, including vitamins C and E, selenium, coenzyme Q10, and polyphenols, are explored in the context of their mechanisms of action and potential clinical applications. The review delves into the implications of antioxidant supplementation on fertility, implantation, and early embryonic development, providing insights into optimizing reproductive success. The clinical applications of antioxidants in pregnancy are explored, encompassing patient-specific factors and potential challenges in interpreting study results.

Introduction

Pregnancy represents a remarkable period of physiological adaptation, where the maternal body undergoes intricate changes to nurture and sustain fetal development. However, this transformative process is not without challenges, and oxidative stress emerges as a critical factor influencing both maternal well-being and fetal outcomes. Oxidative stress results from an imbalance between the production of reactive oxygen species (ROS) and the body’s antioxidant defense mechanisms, creating a state of increased cellular vulnerability [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11]. This paper aims to explore the role of antioxidants as vital components in maintaining the delicate equilibrium required for successful pregnancy and optimal fetal development. The journey through pregnancy involves dynamic alterations in hormonal, metabolic, and immunological profiles, all of which contribute to an increased susceptibility to oxidative stress. Understanding the implications of oxidative stress on maternal health and fetal outcomes sets the stage for investigating the potential benefits of antioxidant interventions. Pregnancy is characterized by a myriad of physiological changes, including increased metabolic demands, alterations in hormonal levels, and adjustments in the immune system. These changes, while essential for fetal development, also contribute to an environment conducive to oxidative stress [12, 13, 14, 15, 16]. Oxidative stress arises when the production of ROS surpasses the body’s antioxidant capacity. In the context of pregnancy, this phenomenon is accentuated, leading to potential cellular damage, inflammation, and adverse outcomes such as preeclampsia, preterm birth, and fetal growth restriction [17, 18, 19, 20, 21].

Antioxidants act as essential defense mechanisms against oxidative stress by neutralizing ROS and preventing cellular damage. The body’s adaptive responses to oxidative stress during pregnancy, including the activation of endogenous antioxidant systems, are explored. Understanding these adaptive mechanisms provides insights into the intricate balance required for maintaining maternal health and supporting fetal development [22, 23, 24, 25, 26].

Antioxidants play a crucial role in optimizing fertility by modulating oxidative stress levels. Evidence supporting the influence of antioxidants on reproductive success, implantation, and early embryonic development is discussed, offering implications for assisted reproductive technologies and natural conception [27, 28, 29, 30, 31]. Antioxidant applications in clinical practice involve considerations of patient-specific factors, including gestational age, underlying medical conditions, and potential interactions with standard obstetric care [32, 33, 34, 35, 36].

Oxidative Stress in Pregnancy

Pregnancy is a dynamic physiological state marked by intricate adaptations to support fetal development. Amidst the myriad changes, oxidative stress emerges as a crucial player, influencing maternal health and impacting fetal outcomes. The heightened metabolic demands of pregnancy, driven by increased energy expenditure and oxygen consumption, contribute to the generation of reactive oxygen species (ROS). Dynamic hormonal fluctuations, including changes in estrogen, progesterone, and placental hormones, further contribute to oxidative stress. The interplay between hormones and ROS production is examined, emphasizing the multifaceted nature of oxidative stress regulation during gestation [37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47].

ROS, including superoxide anions and hydrogen peroxide, target cellular components such as lipids, proteins, and nucleic acids [48]. The consequences of oxidative damage to these crucial cellular structures are explored, providing insights into the potential repercussions on maternal and fetal health. Mitochondria, essential cellular organelles, are particularly vulnerable to oxidative stress. The impact of mitochondrial dysfunction on cellular bioenergetics and its implications for pregnancy-associated pathologies, such as preeclampsia, are discussed. To counterbalance oxidative stress, the body activates endogenous antioxidant defense mechanisms [49, 50, 51, 52, 53]. Beyond neutralizing ROS, oxidative stress also acts as a signaling molecule, influencing various cellular pathways. Preeclampsia, a hypertensive disorder of pregnancy, is closely linked to oxidative stress. Oxidative stress is implicated in preterm birth and intrauterine growth restriction. Lifestyle factors, including diet and exercise, influence oxidative stress levels during pregnancy [54, 55, 56].

Role of Antioxidants

Antioxidants play a pivotal role in the intricate dance of cellular balance, serving as guardians against the deleterious effects of oxidative stress during pregnancy [57]. Antioxidants encompass a diverse array of compounds that counteract oxidative stress by neutralizing reactive oxygen species (ROS). Antioxidants can be obtained through dietary sources or synthesized within the body. The primary mechanism of antioxidants involves directly scavenging ROS, preventing oxidative damage to cellular components. Some antioxidants act by regenerating endogenous antioxidants, such as glutathione. Antioxidants contribute to maternal health by preserving the integrity of maternal cells and tissues [58]. The impact of antioxidants on mitigating oxidative stress- related damage to maternal organs, such as the placenta and vascular system, is explored. Beyond their role in oxidative stress, antioxidants exhibit anti-inflammatory properties. Antioxidants play a crucial role in optimizing fetal growth and development. Fetal tissues are particularly vulnerable to oxidative stress, and antioxidants act as shields against potential damage. Antioxidants are increasingly recognized for their potential in reproductive medicine. Antioxidant supplementation during pregnancy is a subject of interest [59].

Impact on Reproductive Success

Oxidative stress can adversely affect female fertility by impacting oocyte quality, ovarian function, and the integrity of the reproductive tract. Antioxidants may play a role in improving ovulatory function, ensuring the release of high- quality oocytes. Oxidative stress is a recognized contributor to male infertility, affecting sperm motility, morphology, and DNA integrity. Antioxidants may protect sperm DNA from oxidative damage, potentially reducing the risk of genetic abnormalities and improving the chances of successful fertilization [60]. A receptive uterine environment is crucial for successful implantation. Antioxidants may influence endometrial receptivity by modulating oxidative stress and inflammation. Early embryonic development is a vulnerable period where oxidative stress can jeopardize the viability of the developing embryo. Antioxidants may contribute to the reduction of early embryo mortality by safeguarding against oxidative stress-induced apoptosis. The use of antioxidants in assisted reproductive technologies (ART) is a growing area of interest. Exploring combination therapies involving antioxidants and other interventions, such as lifestyle modifications or hormonal treatments, is discussed. Optimal dosing and timing of antioxidant supplementation is critical considerations. The review discusses studies exploring different dosage regimens and the potential influence.

Fetal Development and Long-Term Outcomes

Fetal development is a dynamic and intricate process that sets the foundation for an individual’s lifelong health [61]. Antioxidants may positively influence angiogenesis, promoting the development of a robust vascular network within the placenta. Fetal tissues, particularly during periods of rapid cell division, are susceptible to oxidative stress-induced DNA damage. Antioxidants act as guardians, protecting fetal DNA from oxidative harm and potential long- term consequences such as genetic mutations. Beyond DNA protection, antioxidants contribute to preserving the integrity of cellular structures within developing organs. Antioxidants play a role in cardiovascular development, influencing factors such as heart morphogenesis and vascularization [62]. The developing nervous system is vulnerable to oxidative stress, and antioxidants may impact neurogenesis, synaptogenesis, and myelination. Antioxidants may contribute to reducing the risks associated with fetal programming, where adverse intrauterine conditions influence the susceptibility to chronic diseases later in life. Antioxidants may impact epigenetic modifications, influencing gene expression patterns and long-term health outcomes. Oxidative stress has been implicated in the etiology of certain birth defects. Maternal dietary intake of antioxidants is a crucial determinant of fetal exposure to these compounds. The review discusses the role of maternal nutrition in providing a rich source of antioxidants, influencing fetal development and long- term health outcomes. Balancing the intake of various antioxidants through a diverse and balanced diet is essential for maximizing the potential benefits. This section explores dietary recommendations and considerations for expectant mothers to optimize antioxidant intake.

Nutritional Supplementation

Nutritional supplementation with antioxidants during pregnancy has gained increasing attention for its potential to mitigate oxidative stress, support maternal well-being, and foster optimal fetal development. A balanced and diverse diet provides essential dietary antioxidants crucial for maintaining redox balance. Encouraging the consumption of nutrient-rich foods containing antioxidants is fundamental for ensuring adequate maternal nutrition [63]. Different antioxidants may offer unique benefits, and the selection of antioxidant supplements is a critical consideration. This section discusses common antioxidant supplements used during pregnancy, exploring their individual contributions to maternal and fetal health. Determining optimal dosages for antioxidant supplementation is a complex task. The timing of antioxidant supplementation during pregnancy is explored in the context of critical windows of fetal development. Considerations for initiating supplementation before conception, during early gestation, and throughout the various trimesters are discussed. Antioxidant supplementation aims to reduce oxidative stress in the maternal system. Beyond oxidative stress, antioxidants may influence inflammatory processes during pregnancy. Antioxidant supplementation is linked to enhanced fetal growth, with potential implications for birth weight and overall fetal development. Antioxidants may play a protective role against birth defects linked to oxidative stress. Antioxidants, particularly those with neuroprotective properties, may influence neurocognitive outcomes in offspring. Antioxidants may be associated with a reduced risk of neurodevelopmental disorders in offspring [64, 65, 66, 67, 68, 69].

Recommendations

Conduct a thorough individualized assessment of expectant mothers, considering factors such as maternal age, medical history, pre-existing conditions, and lifestyle factors. Tailor antioxidant supplementation plans to address unique needs and risks. Foster collaboration between healthcare providers, including obstetricians, nutritionists, and researchers, to develop comprehensive healthcare plans that integrate antioxidant supplementation into prenatal care. Consider potential interactions with prenatal vitamins and coordinate care to optimize outcomes. Consider the timing of antioxidant supplementation during pregnancy, recognizing critical windows of fetal development. Initiate supplementation before conception or early in gestation to maximize potential benefits for both maternal and fetal health. Determine optimal dosages of antioxidants based on a careful review of existing evidence. Consider the delicate balance required for redox homeostasis and avoid excessive supplementation, taking into account variations in individual needs and responses.

Implement monitoring strategies to assess maternal and fetal redox status during antioxidant supplementation. Utilize biomarkers of oxidative stress to gauge the effectiveness of interventions and make informed adjustments as needed. Advocate for and participate in long-term follow-up studies to assess the enduring effects of antioxidant supplementation on both maternal and offspring health. Contribute to the growing body of evidence that extends beyond the perinatal period. Provide comprehensive education and counseling to expectant mothers regarding the benefits and potential risks of antioxidant supplementation. Empower

women to make informed decisions about their prenatal care, considering the evolving landscape of antioxidant research. Support and engage in ongoing research efforts to explore emerging trends in antioxidant interventions during pregnancy. Contribute to the development of novel compounds, combination therapies, and personalized medicine approaches that may enhance the efficacy of antioxidant supplementation. Embrace an interdisciplinary approach that involves collaboration between healthcare providers, researchers, and other relevant professionals. Foster dialogue and knowledge exchange to advance the collective understanding of antioxidant supplementation in the context of pregnancy. Actively participate in translating research findings into evidence-based clinical practices. Bridge the gap between scientific knowledge and actionable recommendations to ensure that expectant mothers receive the most current and beneficial care.

Conclusion

The intricate interplay between oxidative stress and pregnancy outcomes has spurred growing interest in the clinical applications of antioxidant supplementation. As we conclude this comprehensive exploration, it is evident that antioxidants wield considerable potential in shaping maternal and fetal health. However, navigating the complexities and challenges associated with their use requires a nuanced understanding and ongoing research efforts. Antioxidant supplementation offers a promising avenue for maintaining redox balance during pregnancy. From mitigating oxidative stress and inflammation to safeguarding maternal and fetal cellular structures, antioxidants play a multifaceted role in preserving the delicate equilibrium crucial for optimal maternal-fetal health. The clinical applications of antioxidant supplementation extend across preventive strategies for pregnancy complications, support for assisted reproductive technologies, and potential long-term benefits. From reducing the risk of hypertensive disorders to enhancing fetal growth and neurocognitive outcomes, antioxidants present diverse opportunities for positively influencing the trajectory of pregnancy.

References

  1. Demirci-Çekiç S, Özkan G, Avan AN, Uzunboy S, Çapanoğlu E, et al. (2022) Biomarkers of oxidative stress and antioxidant defense. Journal of pharmaceutical and biomedical analysis 209: 114477.
  2. Obeagu EI, Agreen FC (2023) Anaemia among pregnant women: A review of African pregnant teenagers. J Pub Health Nutri 6(1): 138.
  3. Obeagu EI, Ezimah ACU, Obeagu GU (2016) Erythropoietin in the anaemias of pregnancy: a review. Int J Curr Res Chem Pharm Sci 3(3): 10-18.
  4. Obeagu JI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, et al. (2021) Assessment of Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci 9(4): 145-148.
  5. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2): 10-13.
  6. Jakheng SPE, Obeagu EI (2022) Seroprevalence of human immunodeficiency virus based on demographic and risk factors among pregnant women attending clinics in Zaria Metropolis, Nigeria. J Pub Health Nutri 5(6): 127.
  7. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF (2022) Evaluation of Protein C, Protein S and Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of Medicine and Health Sciences 2(2): 1-9.
  8. Obeagu EI, Ikpenwa JN, Chukwueze CM, Obeagu GU (2022) Evaluation of protein C, protein S and fibrinogen of pregnant women in Owerri Metropolis. Madonna University Journal of Medicine and Health Sciences 2(1): 292-298.
  9. Obeagu EI, Uzoma G, Joseph AO (2022) Evaluation of haematological parameters of pregnant women based on age groups in Olorunsogo road area of Ido, Ondo state. J Bio Innov 11(3): 936-941.
  10. Obeagu EI (2022) An update on utilization of antenatal care among pregnant Women in Nigeria. Int J Curr Res Chem Pharm Sci 9(9): 21-26.
  11. Okoroiwu IL, Obeagu EI, Obeagu GU (2022) Determination of clot retraction in preganant women attending antenatal clinic in federal medical centre Owerri, Nigeria. Madonna University Journal of Medicine and Health Sciences 2(2): 91-97.
  12. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ (2021) Evaluation of Changes in Haematological Parameters of Pregnant Women Based on Gestational Age at Olorunsogo Road Area of Ido, Ondo State. Nigeria. Journal of Research in Medical and Dental Science 9(12): 462-464.
  13. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, et al. (2022) ABO blood groups and gestational diabetes among pregnant women attending University of Ilorin Teaching Hospital, Kwara State, Nigeria. International Journal of Research and Reports in Hematology 5(2): 113-121.
  14. Obeagu EI (2023) Gestational Thrombocytopaenia. J Gynecol Women’s Health 25(3): 556163.
  15. Jakheng SPE, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, et al. (2022) Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. South Asian Journal of Research in Microbiology 13(2): 26-31.
  16. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  17. Obeagu EI, Abdirahman BF, Bunu UO, Obeagu GU (2023) Obsterics characteristics that effect the newborn outcomes. Int J Adv Res Biol Sc 10(3): 134-143.
  18. Obeagu EI, Ogunnaya FU (2023) Pregnancy induced Haematological Changes: A Key to Marternal and Child Health. European Journal of Biomedical 10(8): 42-43.
  19. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  20. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, et al. (2017) Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research 5(4): 206.
  21. Eze RI, Obeagu EI, Edet FN (2021) Frequency of Rh Antigen C And c among pregnant women in Sub-Urban area in Eastern Nigeria. Madonna Uni J Med Health Sci 1(1): 19-30.
  22. Obeagu EI, Ofodile AC, Okwuanaso CB (2023) A review of urinary tract infections in pregnant women: Risks factors. J Pub Health Nutri 6(1): 137.
  23. Obeagu EI, Obeagu GU, Musiimenta E (2023) Post partum haemorrhage among pregnant women: Update on risks factors. Int J Curr Res Med Sci 9(2): 14-17.
  24. Obeagu EI, Obeagu GU, Ogunnaya FU (2023) Deep vein thrombosis in pregnancy: A review of prevalence and risk factors. Int J Curr Res Chem Pharm Sci 10(8): 14-21.
  25. Jakheng SPE, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(3): 98-105.
  26. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of some haematological parameters in malaria infected pregnant women in Imo state Nigeria. Int J Curr Res Biol Med 3(9): 1-14.
  27. Onyenweaku FC, Amah HC, Obeagu EI, Nwandikor UU, Onwuasoanya UF (2017) Prevalence of asymptomatic bacteriuria and its antibiotic susceptibility pattern in pregnant women attending private ante natal clinics in Umuahia Metropolitan. Int J Curr Res Biol Med 2(2): 13- 23.
  28. Okoroiwu IL, Chinedu-Madu JU, Obeagu EI, Vincent CCN, Ochiabuto OMTB, et al. (2021) Evaluation of Iron Status, Haemoglobin and Protein Levels of Pregnant Women in Owerri Metropolis. Journal of Pharmaceutical Research International 33(27A): 36-43.
  29. Obeagu EI, Njar VE, Obeagu GU (2023) Infertility: Prevalence and Consequences. Int J Curr Res Chem Pharm Sci 10(7): 43-50.
  30. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of levels of some inflammatory cytokines in preeclamptic women in owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  31. Obeagu EI, Faduma MH, Obeagu GU, Agu CC, Kazibwe S (2023) Ectopic Pregnancy: A Review. Int J Curr Res Chem Pharm Sci 10(4): 40-44.
  32. Obeagu EI, Gamade SM, Obeagu GU (2023) The roles of Neutrophils in pregnancy. Int J Curr Res Med Sci 9(5): 31-35.
  33. Eze R, Obeagu EI, Nwakulite A, Okoroiwu IL, Vincent CCN, et al. (2021) Evaluation of Copper Status and Some Red Cell Parameters of Pregnant Women in Enugu State, South Eastern Nigeria. Journal of Pharmaceutical Research International 33(30A): 67-71.
  34. Obeagu EI, Obeagu GU (2023) Molar Pregnancy: Update of prevalence and risk factors. Int J Curr Res Med Sci 9(7): 25-28.
  35. Obeagu EI, Bunu UO (2023) Factors that influence unmet need for family planning. International Journal of Current Research in Biology and Medicine 8(1): 23-27.
  36. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Barriers to utilization of maternal health services in southern senatorial district of Cross Rivers state, Nigeria. International Journal of Advanced Multidisciplinary Research 4(8): 1-9.
  37. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K (2023) Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth 6(1): 203-211.
  38. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of coagulation parameters in malaria infected pregnant women in Imo state, Nigeria. International Journal of Current Research in Medical Sciences 4(9): 41-49.
  39. Obeagu EI, Obeagu GU (2023) Postpartum haemorrhage among women delivering through spontaneous vaginal delivery: Prevalence and risk factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  40. Obeagu E, Eze RI, Obeagu EI, Nnatuanya IN, Dara EC (2022) Zinc Level in Apparently Pregnant Women in Urban Area. Madonna University journal of Medicine and Health Sciences 2(1): 134-148.
  41. Ogomaka IA, Obeagu EI (2021) Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs) in Orlu LGA of Imo State, Nigeria. Journal of Pharmaceutical Research International 33(41B): 380- 386.
  42. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC (2023) Sickle Cell Anaemia: A Gestational Enigma. Migration 17: 18.
  43. Ifeanyi OE, Uzoma OG (2018) A review on erythropietin in pregnancy. J Gynecol Womens Health 8(3): 1-4.
  44. Ifeanyi OE (2018) A review on pregnancy and haematology. Int J Curr Res Biol Med 3(5): 26-28.
  45. Nwosu DC, Nwanjo HU, Obeagu EI, Ibebuike JE, Ezeama MC, et al. (2015) Changes in liver enzymes and lipid profile of pregnant women with malaria in Owerri, Nigeria. International Journal of Current Research and Academic Review 3(5): 376-383.
  46. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Factors that influence women’s utilization of primary health care services in Calabar Cros river state, Nigeria. Int J Curr Res Chem Pharm Sci 4(7): 28-33.
  47. Eze R, Ezeah GA, Obeagu EI, Omeje C, Nwakulite A (2021) Evaluation of iron status and some haematological parameters of pregnant women in Enugu, South Eastern Nigeria. World Journal of Pharmaceutical and Medical Research 7(5): 251-254.
  48. Juan CA, Lastra JMPDL, Plou FJ, Pérez-Lebeña E (2021) The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. International Journal of Molecular Sciences 22(9): 4642.
  49. Queen E, Obeagu EI, Ochei KC (2014) Prevalence of Anaemia among Pregnant Women in Braithwaite Memorial Specialist Hospital (BMSH) Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences 9(5): 59-64.
  50. Akandinda M, Obeagu EI, Katonera MT (2022) Non- Governmental Organizations and Women’s Health Empowerment in Uganda: A Review. Asian Research Journal of Gynaecology and Obstetrics 8(3): 12-6.
  51. Vidya S, Sunil K, Shango PEJ, Emmanuel IO, Emmanuel WJ, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(1): 98-105.
  52. Gamde MS, Obeagu EI, Obeagu GU, Chindo IE, Ramos GF, et al. (2023) Iron Deficiency Anaemia: Enemical To Pregnancy. European Journal of Biomedical 10(9): 272- 275.
  53. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of levels of some inflammatory cytokines in preeclamptic women in owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  54. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Studies of Some Haemostatic Variables in Preeclamptic Women in Owerri, Imo State, Nigeria. Journal of Pharmaceutical Research International 33(42B): 39-48.
  55. Obeagu EI, Obeagu GU (2023) postpartum haemorrhage among women delivering through spontaneous vaginal delivery: Prevalence and risk factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  56. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2): 10-13.
  57. Saras TP (2023) Unlocking the Power of Vitamins: A Comprehensive Guide to Optimal Health. Tiram Media.
  58. Hussain T, Murtaza G, Metwally E, Kalhoro DH, Kalhoro MS, et al. (2021) The role of oxidative stress and antioxidant balance in pregnancy. Mediators of Inflammation 2021: 9962860.
  59. Diniz MS, Magalhaes CC, Tocantins C, Grilo LF, Teixeira J, et al. (2023) Nurturing through Nutrition: Exploring the Role of Antioxidants in Maternal Diet during Pregnancy to Mitigate Developmental Programming of Chronic Diseases. Nutrients 15(21): 4623.
  60. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S (2012) The effects of oxidative stress on female reproduction: a review. Reproductive biology and endocrinology 10(49): 1-31.
  61. Halfon N, Forrest CB (2018) The emerging theoretical framework of life course health development. Handbook of life course health development, pp: 19-43.
  62. Sauer H, Wartenberg M (2005) Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxidants & redox signaling 7(11-12): 1423-1434.
  63. Sebastiani G, Navarro-Tapia E, Almeida-Toledano L, Serra-Delgado M, Paltrinieri AL, et al. (2022) Effects of antioxidant intake on fetal development and maternal/ neonatal health during pregnancy. Antioxidants 11(4): 648.
  64. Obeagu EI, Obeagu GU, Obiezu J, Ezeonwumelu C, Alum EU (2023) Antioxidants and Pregnancy: Impact on Maternal and Fetal Health. Applied Sciences (Nijbas) 4(1).
  65. Obeagu EI, Ubosi NI, Uzoma G (2023) Antioxidant Supplementation in Pregnancy: Effects on Maternal and Infant Health. Int J Adv Multidiscip Res 10(11): 60-70.
  66. Obeagu EI (2024) Antioxidants and Pregnancy Complications: Exploring Therapeutic Strategies for Better Outcomes. Obstet Gynecol 7: 001-006.
  67. Obeagu EI, Obeagu GU, Igwe MC, Alum EU, Ugwu OP (2023) Neutrophil-Derived Inflammation and Pregnancy Outcomes. Newport International Journal of Scientific and Experimental Sciences 4(2): 10-19.
  68. Obeagu E, Eze RI, Obeagu EI, Nnatuanya IN, Dara EC (2022) Zinc Level In Apparently Pregnant Women In Urban Area. Madonna University journal of Medicine and Health Sciences 2(1): 134-148.
  69. Obeagu EI (2023) Mitigating Hemolysis in Pregnancy: Strategies for Managing Sickle Cell Anemia. Int J Curr Res Med Sci 9(11): 29-32.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{obeagu2024,
  title   = {Harnessing Antioxidants for Enhanced Pregnancy Success and 
Fetal Development},
  author  = {Obeagu EI*and Obeagu GU},
  journal = {Open Access Journal of Gynecology},
  year    = {2024},
  volume  = {9},
  number  = {1},
  doi     = {10.23880/oajg-16000282}
}
Obeagu EI*and Obeagu GU (2024). Harnessing Antioxidants for Enhanced Pregnancy Success and 
Fetal Development. Open Access Journal of Gynecology, 9(1). https://doi.org/10.23880/oajg-16000282
TY  - JOUR
TI  - Harnessing Antioxidants for Enhanced Pregnancy Success and 
Fetal Development
AU  - Obeagu EI*and Obeagu GU
JO  - Open Access Journal of Gynecology
PY  - 2024
VL  - 9
IS  - 1
DO  - 10.23880/oajg-16000282
ER  -